SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+12.42%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$215M
AUM Growth
+$215M
(+2.4%)
Cap. Flow
-$11.2M
Cap. Flow
% of AUM
-5.22%
Top 10 Holdings %
Top 10 Hldgs %
32.15%
Holding
71
New
17
Increased
13
Reduced
23
Closed
12
Top Buys
| 1 |
Baxter International
BAX
|
$5.71M |
| 2 |
Revvity
RVTY
|
$5.23M |
| 3 |
Zimmer Biomet
ZBH
|
$4.88M |
| 4 |
HCA Healthcare
HCA
|
$4.67M |
| 5 |
Abbott
ABT
|
$4.44M |
Top Sells
| 1 |
iShares Biotechnology ETF
IBB
|
$9.29M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$6.42M |
| 3 |
Gilead Sciences
GILD
|
$5.73M |
| 4 |
AstraZeneca
AZN
|
$4.52M |
| 5 |
Centene
CNC
|
$4.28M |
Sector Composition
| 1 | Healthcare | 88.35% |
| 2 | Financials | 3.26% |
| 3 | Energy | 1.24% |
| 4 | Consumer Staples | 0% |
| 5 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Biogen
BIIB
$19.4B
| $4.1M | 1.91% |
15,000
-5,000
| -25% | -$1.37M |
|
27
Tenet Healthcare
THC
$16.3B
| $3.99M | 1.86% |
+225,000
| New | +$3.99M |
|
28
Cencora
COR
$56.5B
| $3.98M | 1.85% |
45,000
-5,000
| -10% | -$443K |
|
|
29
AstraZeneca
AZN
$248B
| $3.89M | 1.81% |
125,000
-145,000
| -54% | -$4.52M |
|
30
Thermo Fisher Scientific
TMO
$186B
| $3.84M | 1.79% |
25,000
+5,000
| +25% | +$768K |
|
31
Becton Dickinson
BDX
$55.3B
| $3.67M | 1.71% |
20,000
-5,000
| -20% | -$917K |
|
32
Cardinal Health
CAH
$35.5B
| $2.85M | 1.33% |
+35,000
| New | +$2.85M |
|
33
Chemed
CHE
$6.67B
| $2.74M | 1.28% |
15,000
| – | – |
|
|
LHCG
34
DELISTED
LHC Group LLC
LHCG
| $2.66M | 1.24% |
49,405
+14,405
| +41% | +$776K |
|
|
BCR
35
DELISTED
CR Bard Inc.
BCR
| $2.49M | 1.16% |
10,000
-10,000
| -50% | -$2.49M |
|
36
Viatris
VTRS
$12.3B
| $2.34M | 1.09% |
+60,000
| New | +$2.34M |
|
37
Acadia Pharmaceuticals
ACAD
$4.38B
| $2.24M | 1.04% |
65,000
-5,000
| -7% | -$172K |
|
|
PRXL
38
DELISTED
Parexel International Corp
PRXL
| $2.21M | 1.03% |
35,000
+5,000
| +17% | +$316K |
|
39
Bausch Health
BHC
$2.74B
| $2.21M | 1.03% |
+200,000
| New | +$2.21M |
|
40
Acadia Healthcare
ACHC
$2.12B
| $2.18M | 1.02% |
+50,000
| New | +$2.18M |
|
41
Smith & Nephew
SNN
$16.3B
| $2.17M | 1.01% |
70,000
-15,000
| -18% | -$464K |
|
|
IPXL
42
DELISTED
Impax Laboratories, Inc.
IPXL
| $2.13M | 0.99% |
168,030
+63,030
| +60% | +$797K |
|
|
AMED
43
DELISTED
Amedisys
AMED
| $1.77M | 0.82% |
34,607
+13,097
| +61% | +$669K |
|
44
Intuitive Surgical
ISRG
$170B
| $1.73M | 0.8% |
2,250
-750
| -25% | -$575K |
|
45
Illumina
ILMN
$15.8B
| $1.71M | 0.79% |
+10,000
| New | +$1.71M |
|
46
Perrigo
PRGO
$3.27B
| $1.66M | 0.77% |
+25,000
| New | +$1.66M |
|
|
TSRO
47
DELISTED
TESARO, Inc.
TSRO
| $1.62M | 0.75% |
+10,500
| New | +$1.62M |
|
|
DPLO
48
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $1.61M | 0.75% |
+101,000
| New | +$1.61M |
|
49
Teva Pharmaceuticals
TEVA
$21.1B
| $1.61M | 0.75% |
+50,000
| New | +$1.61M |
|
50
ResMed
RMD
$40.2B
| $1.53M | 0.71% |
21,200
-23,800
| -53% | -$1.71M |
|